353 filings
6-K
SCNI
Scinai Immunotherapeutics Ltd
28 May 24
Report of Foreign Private Issuer
2:14pm
424B3
SCNI
Scinai Immunotherapeutics Ltd
16 May 24
Prospectus supplement
1:49pm
6-K
SCNI
Scinai Immunotherapeutics Ltd
15 May 24
Scinai Publishes FY 2023 Financial Statements, Files Annual Report on Form 20-F and Provides Business Update
5:10pm
6-K
SCNI
Scinai Immunotherapeutics Ltd
7 May 24
Scinai Immunotherapeutics Announces Receipt of Nasdaq Delisting Notification and Appeal
10:24am
NT 20-F
oijs9
30 Apr 24
Notice of late annual filing (foreign)
4:06pm
6-K
sqebid 5b7oi
25 Apr 24
Report of Foreign Private Issuer
4:00pm
6-K
o161nu iuo7uwz
16 Apr 24
Report of Foreign Private Issuer
5:27pm
EFFECT
52wpa 9cdge6z8i
14 Feb 24
Notice of effectiveness
12:15am
CORRESP
us6qc4zlf zllk9
9 Feb 24
Correspondence with SEC
12:00am
UPLOAD
qxru5t daa66
2 Feb 24
Letter from SEC
12:00am
F-3
ke38h6wyljjieqp uti
30 Jan 24
Shelf registration (foreign)
4:19pm
6-K
mz67nz 6zlevi
18 Jan 24
Report of Foreign Private Issuer
11:50am
D
f5vnt5fx6a2oq
12 Jan 24
$1.69 mm in equity / options / securities to be acquired, sold $1.69 mm, 4 investors
7:32am
6-K
ravaqq51
9 Jan 24
Report of Foreign Private Issuer
8:45am
6-K
a64lejmjpe4y5q0ia
4 Jan 24
Scinai Immunotherapeutics CEO Issues Letter to Shareholders
4:37pm
424B3
d9vaqlp
2 Jan 24
Prospectus supplement
9:58am
424B3
ef88bd0fq87a
2 Jan 24
Prospectus supplement
9:57am
6-K
8a8jh2lifo9lj
2 Jan 24
Report of Foreign Private Issuer
9:26am
6-K
7nn14u4
2 Jan 24
Scinai Immunotherapeutics Announces Exercise of Outstanding Warrants for $1.69 Million in Gross Proceeds
9:24am